Skip to main content

Advertisement

SpringerLink
Log in

Registries and artificial intelligence: investing in the future of hematopoietic cell transplantation

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Beam A, Kohane I. Big data and machine learning in health care. JAMA. 2018;319:1317–8.

    Article  Google Scholar 

  2. Pasquini MC, Logan B, Jones RJ, Appelbaum FR, Bolaños-Meade J, Flowers MED, et al. Blood and marrow transplant clinical trials network report on development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials. Biol Blood Marrow Transplant. 2018;24:1274–80.

    Article  Google Scholar 

  3. Cabitza F, Rasoini R, Gensini GF. Unintended consequences of machine learning in medicine. JAMA. 2017;318:517–8.

    Article  Google Scholar 

  4. Char D, Shah N, Magnus D. Implementing machine learning in health are — addressing ethical challenges. New Engl J Med. 2018;378:981–3.

    Article  Google Scholar 

  5. Gandelman JS, Byrne MT, Mistry AM, Polikowsky H, Diggins KE, Chen H, et al. Machine learning reveals patient phenotypes and stratifies outcomes in chronic graft-versus host disease. Biol Blood Marrow Transplant. 2018;24:S65.

    Article  Google Scholar 

  6. Buturovic L, Shelton J, Spellman S, Wang T, Friedman L, Loftus D, et al. Evaluation of a machine learning-based prognostic model for unrelated hematopoietic cell transplantation donor selection. Biol Blood Marrow Transplant. 2018;24:1299–306.

    Article  Google Scholar 

  7. Shouval R, Labopin M, Bondi O, Mishan-Shamay H, Shimoni A, Ciceri F, et al. Prediction of allogeneic hematopoietic stem cell transplantation mortality 100 days after transplantation using a machine learning algorithm: a European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining Study. J Clin Oncol. 2015;33:3144–51.

    Article  Google Scholar 

  8. Hussain F, Chaudhri N, Alfraih F, Aljurf M. Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries. Hematol/Oncol Stem Cell Ther. 2017;10:203–10.

    Article  Google Scholar 

  9. Somashekhar S, Sepúlveda M, Puglielli S, Norden A, Shortliffe E, Rohit Kumar C, et al. Watson for Oncology and breast cancer treatment recommendations: agreement with an expert multidisciplinary tumor board. Ann Oncol. 2018;29:418–23.

    Article  CAS  Google Scholar 

  10. Powles J, Hodson H. Google DeepMind and healthcare in an age of algorithms. Health Technol. 2017;7:351–67.

    Article  Google Scholar 

  11. CancerLinQ Engages Leading Technology Companies Tempus and Precision HealthAI to Accelerate Data-Driven Insights to Oncologists and the Cancer Care Community [Internet]. ASCO. 2018 [Accessed 2 July 2018]. Available from: https://www.asco.org/about-asco/press-center/news-releases/cancerlinq-engages-leading-technology-companies-tempus-and

  12. Schmidt C. M.D. Anderson breaks with IBM Watson, raising questions about artificial intelligence in oncology. J Natl Cancer Inst. 2017;109:djx113.

Download references

Author information

Authors and Affiliations

  1. College of Medicine, Alfaisal University, Riyadh, Saudi Arabia

    Ibrahim N. Muhsen

  2. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA

    Madan Jagasia

  3. Bone Marrow Transplant program, Massey Cancer Center, VCU, Richmond, VA, USA

    Amir Ahmed Toor

  4. Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    Shahrukh K. Hashmi

  5. Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN, USA

    Shahrukh K. Hashmi

Authors
  1. Ibrahim N. Muhsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madan Jagasia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amir Ahmed Toor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shahrukh K. Hashmi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

IM, MJ, AAT, and SKH participated in writing and revising the manuscript.

Corresponding author

Correspondence to Shahrukh K. Hashmi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muhsen, I.N., Jagasia, M., Toor, A.A. et al. Registries and artificial intelligence: investing in the future of hematopoietic cell transplantation. Bone Marrow Transplant 54, 477–480 (2019). https://doi.org/10.1038/s41409-018-0327-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41409-018-0327-x

  • Springer Nature Limited

This article is cited by

Search

Navigation